The anticancer peptide RT53 induces immunogenic cell deathEwa Pasquereau-Kotula(Inserm), Jean‐Luc Poyet(Inserm)PLoS ONEAugust 6, 201810.1371/journal.pone.0201220Cited by 56SaveCiteExport RISWatch citationsRelated PapersRecent Advances in Cell Penetrating Peptide-Based Anticancer Therapies|Molecules|2019|281